What is the current Medical Poly (lactic-co-glycolic acid) (PLGA) market size?

The current Medical Poly (lactic-co-glycolic acid) (PLGA) market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Medical PLGA market?

The Medical PLGA market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Medical PLGA market?

Key drivers include rising healthcare expenditure and growing demand for biodegradable materials in medical applications.

What are the major challenges facing the Medical PLGA market?

Challenges include high production costs and stringent regulatory requirements for medical devices and implants.

Which regions are leading the Medical PLGA market?

North America and Europe are currently leading the market, due to strong healthcare infrastructure and research initiatives.

Who are the top companies in the Medical PLGA market?

Top companies include Evonik, Corbion, and Mitsui Chemicals, which offer a range of PLGA-based products and solutions.

What future opportunities can be expected in the Medical PLGA market?

Future opportunities include growing demand for PLGA-based implants and devices, particularly in emerging markets and applications.

How will technology impact the Medical PLGA market?

Advances in 3D printing and biomaterials technology will drive innovation and growth in the Medical PLGA market, enabling new applications.

What is the current regulatory landscape for the Medical PLGA market?

The regulatory landscape is evolving, with increasing focus on biocompatibility and safety testing for medical devices and implants.

What is the future outlook for the Medical PLGA market?

The future outlook is positive, with growing demand and increasing adoption of PLGA-based products in medical applications expected to drive growth.

Medical Poly (lactic-co-glycolic acid) (PLGA) Growth Trends & Opportunity Analysis 2033

Medical Poly (lactic-co-glycolic acid) (PLGA) by Application (Surgical, Drug Sustained Release, Others), by Types (PLGA 50: 50, PLGA 75: 25, PLGA 90: 10, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 147

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 147

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Medical Poly (lactic-co-glycolic acid) (PLGA) Market Size | CAGR 10.2 Forecast 2033

Medical Poly (lactic-co-glycolic acid) (PLGA) Growth Trends & Opportunity Analysis 2033

🏭 Chemicals & Materials🌍 Global

Pages: 147

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 147

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Poly (lactic-co-glycolic acid) (PLGA) Market Overview

The Medical Poly (lactic-co-glycolic acid) (PLGA) market refers to the industry that produces and supplies PLGA, a biodegradable and biocompatible polymer used in various medical applications. As a crucial component in the development of drug delivery systems, tissue engineering, and medical devices, the Medical Poly (lactic-co-glycolic acid) (PLGA) market size is estimated to be around $1.4 billion. The growth outlook for this market is promising, with a projected market forecast of $3.5 billion by 2033, driven by the increasing demand for biodegradable materials in the medical sector. This industry expansion is expected to be fueled by the rising adoption of PLGA in orthopedic, dental, and ophthalmic applications, among others.

Loading chart…

The Medical Poly (lactic-co-glycolic acid) (PLGA) market is expected to grow at a CAGR of 10.5% during the forecast period, driven by macro drivers such as the increasing demand for biodegradable materials, advancements in medical technology, and the rising awareness of the benefits of PLGA. Key forces shaping the industry include technology shifts towards more sustainable and biocompatible materials, regulatory requirements for the use of biodegradable materials in medical applications, and competitive intensity among market players. The largest region for the Medical Poly (lactic-co-glycolic acid) (PLGA) market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by the increasing adoption of PLGA in the medical sector.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Evonik Industries AG; Corbion NV; Mitsui Chemicals Inc.; Nomisma Healthcare; eSUNMED; Jinan Daigang Biomaterial Co., Ltd.; Shenzhen Polymtek Biomaterial Co., Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Poly (lactic-co-glycolic acid) (PLGA) market is poised for significant growth, driven by increasing demand for biodegradable and biocompatible materials in medical applications. This section outlines the key dynamics influencing the Medical Poly (lactic-co-glycolic acid) (PLGA) market size and growth forecast.

Growth Drivers2 items

Advances in biodegradable technology have expanded the range of applications for Medical Poly (lactic-co-glycolic acid) (PLGA), driving growth in the market and contributing to an increasing Medical Poly (lactic-co-glycolic acid) (PLGA) market size.

Government initiatives and regulatory support for the development of biocompatible materials have created a favorable environment for the Medical Poly (lactic-co-glycolic acid) (PLGA) market, with a positive impact on the growth forecast.

Restraints2 items

High production costs and limited scalability of Medical Poly (lactic-co-glycolic acid) (PLGA) manufacturing processes may hinder market growth and affect the overall Medical Poly (lactic-co-glycolic acid) (PLGA) market size.

Stringent quality control measures and rigorous testing requirements can increase the time and cost associated with bringing new Medical Poly (lactic-co-glycolic acid) (PLGA) products to market, influencing the growth forecast.

Opportunities2 items

Emerging applications in tissue engineering and drug delivery systems are expected to drive demand for Medical Poly (lactic-co-glycolic acid) (PLGA) and contribute to the growth forecast of the Medical Poly (lactic-co-glycolic acid) (PLGA) market.

Increasing focus on sustainability and environmental responsibility is anticipated to boost adoption of biodegradable materials like Medical Poly (lactic-co-glycolic acid) (PLGA), leading to an increase in the Medical Poly (lactic-co-glycolic acid) (PLGA) market size.

Challenges2 items

Ensuring the stability and consistency of Medical Poly (lactic-co-glycolic acid) (PLGA) materials over time remains a significant challenge, affecting the growth forecast and Medical Poly (lactic-co-glycolic acid) (PLGA) market size.

Managing supply chain risks and maintaining a stable supply of high-quality raw materials is crucial to supporting the growth of the Medical Poly (lactic-co-glycolic acid) (PLGA) market and achieving a positive growth forecast.

Market Segmentation

Loading chart…

The Medical Poly (lactic-co-glycolic acid) (PLGA) market can be segmented based on application, which includes drug delivery, tissue engineering, and medical devices. The drug delivery segment holds a significant share of the market, as PLGA is widely used in the development of controlled-release drug delivery systems. This segment contributes to the overall market size by providing a biodegradable and biocompatible material for the delivery of various therapeutic agents.

Another important segmentation category is types, which includes subtypes such as PLGA 50:50, PLGA 65:35, and PLGA 75:25. These subtypes differ in their monomer composition, which affects their physical and chemical properties. The PLGA 50:50 subtype is the most widely used, due to its balanced properties and ease of fabrication. Understanding the Medical Poly (lactic-co-glycolic acid) (PLGA) segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

Medical Poly (lactic-co-glycolic acid) (PLGA) Segmentation Breakdown9 items

Application

Surgical

Drug Sustained Release

Others

Types

PLGA 50: 50

PLGA 75: 25

PLGA 90: 10

Others

Regional Insights

Loading chart…

The Medical Poly (lactic-co-glycolic acid) (PLGA) market is poised for significant growth, driven by increasing adoption in various regions. The largest region, North America, accounts for approximately 35% of the market share, driven by key drivers such as strong investment in research and development, favorable policies, and a mature ecosystem.

The fastest-growing region is Asia Pacific, driven by key drivers such as growing demographics, increasing infrastructure, and rising adoption of PLGA-based products. This region is expected to contribute significantly to the Medical Poly (lactic-co-glycolic acid) (PLGA) market growth, with a regional forecast indicating a substantial increase in market share.

Other regions, such as Europe, Latin America, and Middle East & Africa, also contribute to the market growth, driven by factors such as government initiatives, expanding healthcare infrastructure, and growing demand for PLGA-based products. These regions are expected to play a crucial role in shaping the regional forecast of the Medical Poly (lactic-co-glycolic acid) (PLGA) market.

Competitive Landscape

The Medical Poly (lactic-co-glycolic acid) (PLGA) competitive landscape is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a combination of global players with established brands and local/regional companies with strong distribution networks. Key competitive levers include pricing strategies, distribution partnerships, and product innovation, with companies focusing on developing high-quality products that meet stringent regulatory requirements, thus shaping the Medical Poly (lactic-co-glycolic acid) (PLGA) competitive landscape.

Companies in the Medical Poly (lactic-co-glycolic acid) (PLGA) market employ various strategies to differentiate themselves and maintain a competitive edge. Common strategies include mergers and acquisitions, partnerships, product launches, expansion into new regions, research and development, and localization of products to meet specific regional needs. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks, which can lead to commoditization of products. To overcome these challenges, companies focus on competitive differentiation through technology, service models, channel strength, customization, and cost advantages.

Evonik Industries AG: regional expansion

Corbion NV: innovation pipeline

Mitsui Chemicals Inc.: vertical integration

Nomisma Healthcare: premium pricing

eSUNMED: OEM tie-ups

Jinan Daigang Biomaterial Co., Ltd.: local manufacturing

Key Medical Poly (lactic-co-glycolic acid) (PLGA) Companies7 items

Evonik Industries AG

Corbion NV

Mitsui Chemicals Inc.

Nomisma Healthcare

eSUNMED

Jinan Daigang Biomaterial Co., Ltd.

Shenzhen Polymtek Biomaterial Co., Ltd.

Market Ecosystem

The Medical Poly (lactic-co-glycolic acid) (PLGA) ecosystem encompasses a complex network of upstream, midstream, and downstream participants. Value creation begins with technology providers and suppliers of raw materials, which are then integrated by manufacturers and system integrators. The resulting products are distributed through various channels to end users, including healthcare providers and medical device manufacturers. The value chain analysis of this ecosystem reveals how value is created and captured at each stage, from research and development to commercialization and post-market support.

Raw material suppliers — providing PLGA resins and precursors

Technology providers — developing PLGA synthesis and processing technologies

OEMs / manufacturers — producing PLGA-based medical devices and implants

System integrators / EPCs — integrating PLGA products into larger medical systems

Distributors / channel partners — supplying PLGA products to healthcare providers

Regulators/standards bodies — establishing guidelines and approvals for PLGA products

End users / buyers — purchasing and utilizing PLGA-based medical devices and implants

The flow of value through the Medical Poly (lactic-co-glycolic acid) (PLGA) ecosystem is influenced by control points, such as regulatory approvals and standards, which can impact adoption and penetration of PLGA products. Dependency risks, including input constraints and supply chain disruptions, can also affect the ecosystem. Switching costs and partnerships between participants can influence the level of collaboration and competition. Furthermore, the ecosystem may differ by region due to varying regulatory requirements, market demand, and competitive landscapes, highlighting the need for a nuanced understanding of the Medical Poly (lactic-co-glycolic acid) (PLGA) ecosystem to navigate these complexities effectively.

Recent Industry Insights

The Medical Poly (lactic-co-glycolic acid) (PLGA) industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance research and development capabilities. Recently, there have been strategic mergers and acquisitions, such as the acquisition of a biotechnology firm by a leading PLGA manufacturer, to expand product portfolios and strengthen market presence. Additionally, several product and technology launches have taken place, focusing on innovative applications of PLGA in drug delivery systems and tissue engineering.

Furthermore, regulatory changes have been implemented to ensure the safe use of PLGA in medical applications. There has also been a shift in consumer trends, with a growing preference for biodegradable and sustainable materials. Funding rounds and expansions have been announced by several companies to support the development of new PLGA-based products, driving growth in the Medical Poly (lactic-co-glycolic acid) (PLGA) industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Medical Poly (lactic-co-glycolic acid) (PLGA) market outlook. The market exhibits high attractiveness due to increasing demand for biodegradable materials in medical applications. The competitive intensity is moderate, with key players focusing on innovation and expansion of product portfolios. The long-term outlook remains positive, driven by growing applications in drug delivery systems, tissue engineering, and wound care.

The innovation landscape is dynamic, with ongoing research and development in new technologies and applications. However, the demand–supply balance is challenging, with fluctuations in raw material prices and supply chain disruptions. Key risk factors include regulatory changes and intense competition. Overall, the Medical Poly (lactic-co-glycolic acid) (PLGA) market outlook indicates a promising future, with opportunities for growth and expansion in various medical applications.

11 items

1. Executive Summary

2. Medical Poly (lactic-co-glycolic acid) (PLGA) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Surgical

6.1.2. Drug Sustained Release

6.1.3. Others

6.2. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. PLGA 50: 50

6.2.2. PLGA 75: 25

6.2.3. PLGA 90: 10

6.2.4. Others

6.3. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Competition by Key Manufacturers

8.1. Global Medical Poly (lactic-co-glycolic acid) (PLGA) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Medical Poly (lactic-co-glycolic acid) (PLGA): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Evonik Industries AG

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Corbion NV

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Mitsui Chemicals Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Nomisma Healthcare

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. eSUNMED

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Jinan Daigang Biomaterial Co., Ltd.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Shenzhen Polymtek Biomaterial Co., Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market

Figure 4: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market: Drivers

Figure 5: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market: Challenges

Figure 6: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market: Trends

Figure 7: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market: Opportunity

Figure 8: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market: Restraint

Figure 9: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Value (USD Million) By Region

Figure 15: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Value (USD Million) By Region

Figure 23: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Value (USD Million) By Region

Table 10: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Evonik Industries AG Basic Information And Sales Area

Table 31: Evonik Industries AG. Products Portfolio

Table 32: Corbion NV Basic Information And Sales Area

Table 33: Corbion NV. Products Portfolio

Table 34: Mitsui Chemicals Inc. Basic Information And Sales Area

Table 35: Mitsui Chemicals Inc.. Products Portfolio

Table 36: Nomisma Healthcare Basic Information And Sales Area

Table 37: Nomisma Healthcare. Products Portfolio

Table 38: eSUNMED Basic Information And Sales Area

Table 39: eSUNMED. Products Portfolio

Table 40: Jinan Daigang Biomaterial Co., Ltd. Basic Information And Sales Area

Table 41: Jinan Daigang Biomaterial Co., Ltd.. Products Portfolio

Table 42: Shenzhen Polymtek Biomaterial Co., Ltd. Basic Information And Sales Area

Table 43: Shenzhen Polymtek Biomaterial Co., Ltd.. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Value (USD Million) By Region

Table 49: Global Medical Poly (lactic-co-glycolic acid) (PLGA) Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Medical Poly (lactic-co-glycolic acid) (PLGA) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	27.84 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Evonik Industries AG; Corbion NV; Mitsui Chemicals Inc.; Nomisma Healthcare; eSUNMED; Jinan Daigang Biomaterial Co., Ltd.; Shenzhen Polymtek Biomaterial Co., Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options